What are the ESMO guidelines for staging and risk assessment of Hodgkin lymphoma (Hodgkin disease)?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The ESMO guidelines for staging and risk assessment include the following recommendations [5] :

  • Chest x-ray and a contrast-enhanced CT scan of neck, chest, and abdomen are mandatory

  • A baseline PET should be conducted, if this is available

  • A bone marrow biopsy is not indicated in patients undergoing PET-CT evaluation but must be carried out if PET-CT is not available.

  • Full blood cell count, erythrocyte sedimentation rate (ESR), and blood chemistry analysis are obligatory. Screening for hepatitis B and C viruses and HIV is compulsory.

  • After staging examinations are completed, HL patients are allocated to distinct risk groups depending on their clinical stage and the presence of clinical risk factors

  • Cardiac and pulmonary function tests should be performed out before the start of treatment

  • Reproductive counselling and consideration of sperm banking, oocyte collection, or ovarian tissue cryopreservation should be offered to patients of reproductive age before treatment.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!